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2526Objective: Contemporary outcomes data for complete atrioventricular septal defect (CAVSD) repair are
limited. We sought to describe early outcomes of CAVSD repair across a large multicenter cohort, and explore
potential associations with patient characteristics, including age, weight, and genetic syndromes.
Methods: Patients in the Society of Thoracic Surgeons Congenital Heart Surgery Database having repair of
CAVSD (2008-2011) were included. Preoperative, operative, and outcomes data were described. Univariate
associations between patient factors and outcomes were described.
Results: Of 2399 patients (101 centers), 78.4% had Down syndrome. Median age at surgery was 4.6 months
(interquartile range, 3.5-6.1 months), with 11.8% (n ¼ 284) aged 2.5 months. Median weight at surgery
was 5.0 kg (interquartile range, 4.3-5.8 kg) with 6.3% (n ¼ 151)< 3.5 kg. Pulmonary artery band removal
at CAVSD repair was performed in 122 patients (4.6%). Major complications occurred in 9.8%, including per-
manent pacemaker implantation in 2.7%. Median postoperative length of stay (PLOS) was 8 days (interquartile
range, 5-14 days). Overall hospital mortality was 3.0%. Weight<3.5 kg and age 2.5 months were associated
with higher mortality, longer PLOS, and increased frequency of major complications. Patients with Down
syndrome had lower rates of mortality and morbidities than other patients; PLOS was similar.
Conclusions: In a contemporary multicenter cohort, most patients with CAVSD have repair early in the first year
of life. Prior pulmonary artery band is rare. Hospital mortality is generally low, although patients at extremes of
low weight and younger age have worse outcomes. Mortality and major complication rates are lower in patients
with Down syndrome. (J Thorac Cardiovasc Surg 2014;148:2526-31)The natural history of complete atrioventricular septal
defect (CAVSD) includes premature death due to complica-
tions of congestive heart failure and/or pulmonary artery
hypertension. Repair during infancy is recommended for
all patients. Outcomes following surgical repair have
improved over several decades due to refinements of tech-
nique and postoperative management.1-7 The age for
elective repair has steadily declined, from as late as 1
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The Journal of Thoracic and Cardiovascular Surtoday.6,8-12 Early repair is intended to minimize the risk
of premature death or pulmonary vascular obstructive
disease. There are, however, some patients with medically
refractory congestive heart failure for whom repair even
earlier in infancy must be considered, because the risk of
adverse events during prolonged supportive medical
therapy is substantial. Single-stage repair is generally
preferred, but occasionally palliation with pulmonary artery
banding (PAB) is considered.
Although the benefits of surgical repair before age 6
months are now generally acknowledged, optimal timing
is still debated and is unlikely to be the same for all patients.
A recent study by Atz and the Pediatric Heart Network
(PHN) Investigators9 reported outcomes of 120 patients
who underwent repair of CAVSD at 7 centers. Adverse out-
comes were negatively correlated with age at repair from
birth to age 2.5 months, but did not vary by age beyond
2.5 months. There is a paucity of other multicenter studies
addressing this issue.
CAVSD is frequently associated with Down syndrome.10
Associations between Down syndrome and contemporary
outcomes remain to be established. Infants with Down syn-
drome and left-to-right shunts have long been believed to be
susceptible to pulmonary vascular reactivity and respiratory
complications. Despite these risks, our previous analysis ofgery c December 2014
Abbreviations and Acronyms
CAVSD ¼ complete atrioventricular septal defect
IQR ¼ interquartile range
PAB ¼ pulmonary artery banding
PHN ¼ Pediatric Heart Network
PLOS ¼ postoperative length of stay
STS-CHSD ¼ Society of Thoracic Surgeons
Congenital Heart Surgery Database
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geons Congenital Heart Surgery Database (STS-CHSD)
showed that mortality rates for patients with or without
Down syndrome did not differ significantly across the spec-
trum of pediatric cardiac surgical procedures. Lengths of
stay were prolonged for patients with Down syndrome un-
dergoing some specific procedures, but CAVSD repair
was not one of those.13
Apart from the PHN study,9 there are no recent large
multicenter studies pertaining to surgical outcomes among
infants with CAVSD. The aim of our study is to provide a
descriptive analysis of contemporary multicenter experi-
ence with repair of CAVSD using data from the STS-
CHSD.FIGURE 1. Discharge mortality by weight at surgery for the entire cohort
of patients undergoing repair of complete atrioventricular septal defect
during the period 2008 to 2011.PATIENTS AND METHODS
Data Source
The STS-CHSD contains operative, perioperative, and outcomes data
on more than 250,000 patients undergoing congenital heart surgery since
1998, and currently includes information from 108 participating hospitals.
Data quality and reliability are assured through intrinsic verification of data
and a formal process of site visits and data audits. The Duke Clinical
Research Institute serves as the data warehouse and analytic center for
all of the STS National Databases. This analysis was approved by the
Duke University Institutional Review Board, and by the STS Access and
Publications Committee. This study was not considered human subjects
research by the Duke University Institutional Review Board in accordance
with the common rule (45 CFR 46.102(f)).
Patient Population
All STS-CHSD records from 2008 to 2011 with the procedure code for
CAVSD repair entered for the index operation were identified. Patients
with concomitant diagnosis of tetralogy of Fallot, total anomalous pulmo-
nary venous connection, double outlet right ventricle, or any form of sin-
gle ventricle (including single ventricle unbalanced antrioventricular
canal or single ventricle heterotaxy syndrome) were excluded. Cases
were analyzed on the basis of the first CAVSD operation of each admis-
sion. Patients with missing or invalid data for key variables were
excluded.
Data Collection
Patient characteristics included age, weight, weight-for-age z-score,
gender, race/ethnicity, additional preoperative factors (as defined by the
STS-CHSD), noncardiac congenital anatomic abnormalities, chromosomal
abnormalities or syndromes, and prior cardiac surgical procedures. Proce-
dural factors include cardiopulmonary bypass, crossclamp times, and con-
current procedures.The Journal of Thoracic and CarOutcomes
The primary outcome was discharge mortality. Postoperative length of
stay (PLOS) was calculated from date of operation to date of hospital
discharge. Both the occurrence of any postoperative complication collected
in the STS-CHSD, as well as major complications were evaluated. The
latter include renal failure requiring dialysis, neurologic deficit persisting
at discharge, arrhythmia requiring permanent pacemaker, mechanical cir-
culatory support, phrenic nerve injury/paralyzed diaphragm, and un-
planned reoperation/reintervention.14
Analysis
Distributions of patient characteristics and outcomes were summarized
in the overall sample, in patients with Down syndrome and those without,
as well as in patient groups defined by age and weight at surgery. Specif-
ically, the age groups (2.5 and>2.5 months) were defined based on find-
ings previously reported by the PHN investigators9 and 3.5 kg was chosen
as the threshold for low and high weight groups (<3.5 kg and3.5 kg) after
an initial exploration of dischargemortality by weight at surgery (Figure 1).
In all groups, we reported the frequencies of categorical variables and the
median values with interquartile ranges of continuous variables. Patient
characteristics and outcomes were described between groups and
compared using the c2 and Wilcoxon rank sum tests where appropriate.
Due to the descriptive nature of this study, multivariable analyses were
not undertaken. It is known that several key anatomic and physiologic vari-
ables that may influence outcome in this patient population are not
currently collected in the STS-CHSD, thus limiting the utility and results
of multivariable modeling to attempt to identify independent risk factors
for adverse outcomes. All analyses were performed using SAS version
9.3 (SAS Institute, Inc, Cary, NC). A P value< .05 was considered statis-
tically significant.RESULTS
Patient Population
The cohort included 2399 patients over the 4 years of data
collection (Table 1). Overall, 43% (n ¼ 1040) of patients
were male and 78% (n ¼ 1882) had Down syndrome.diovascular Surgery c Volume 148, Number 6 2527
TABLE 1. Study population characteristics for the combined overall cohort and for those with or without Down syndrome
Characteristic Overall (N ¼ 2399)
Down syndrome
(n ¼ 1882)
Non-Down syndrome
(n ¼ 517) P value
Age, d 138.0 (104.0 to 182.0) 137.0 (106.0 to 176.0) 143.0 (95.0 to 225.0) .0432
Weight, kg 5.0 (4.3 to 5.8) 5.0 (4.3 to 5.7) 5.0 (4.2 to 6.6) .0048
Weight for age z-score 2.3 (3.1 to 1.5) 2.3 (3.1 to 1.5) 2.0 (2.8 to 1.3) <.0001
Male gender 1040 (43.4) 830 (44.1) 210 (40.6) .1585
Antenatal diagnosis of congenital heart disease 782 (32.6) 648 (34.4) 134 (25.9) .0001
Surgery year .0250
2008 595 (24.8) 449 (23.9) 146 (28.2)
2009 651 (27.1) 524 (27.8) 127 (24.6)
2010 535 (22.3) 407 (21.6) 128 (24.8)
2011 618 (25.8) 502 (26.7) 116 (22.4)
Values are given as median (interquartile range) or n (%).
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D One-third of all patients had antenatal diagnosis of CAVSD.
This differed between Down syndrome and non-Down syn-
drome patients (34% vs 26%, respectively; P ¼ .0001).
Median age at surgery was 4.6 months (interquartile range
[IQR], 3.5-6.1) with 11.8% (n ¼ 284) aged 2.5 months.
Median weight at surgery was 5.0 kg (IQR, 4.3-5.8) with
6.3% (n ¼ 151) weighing<3.5 kg. Noncardiac congenital
anatomic abnormalities (coded in the STS-CHSD since
2010) were present in 4% of cases (43 out of 1099).Preoperative Factors
Twenty-eight percent of all patients had1 of the 34 pre-
operative factors collected in the STS-CHSD. The most
common preoperative factor was mechanical ventilatory
support (Table 2). Compared with patients with Down syn-
drome, those without Down syndrome had a higher fre-
quency of mechanical ventilatory support (7% vs 4%;
P ¼ .0035) and preoperative seizures (2% vs 1%;
P<.01). Non-Down syndrome patients also had a higher
frequency of the composite variable ‘‘any major preopera-
tive factor’’ (7% vs 4%; P ¼ .0045). Overall, 9% of the
cohort had undergone at least 1 major cardiothoracic oper-
ation before having complete repair of the CAVSD.
The prevalence of 1 preoperative factors was greater in
patients undergoing repair at age  2.5 months (36% vs
27%, respectively; P ¼ .001), as shown in Table 3.TABLE 2. Preoperative factors for the combined overall cohort and for th
Preoperative factor
Overall
(N ¼ 2399)
Mechanical circulatory support* 4 (0.2)
Mechanical ventilatory support* 110 (4.6)
Renal dysfunction* 4 (0.2)
Shock – persistent* 0 (0)
Seizures 29 (1.2)
Septicemia 21 (0.9)
Any major preoperative factors 115 (4.8)
Any Society of Thoracic Surgeons preoperative factors 667 (27.8)
Values are given as n (%). NA, Not available. *Individual preoperative factor included in
2528 The Journal of Thoracic and Cardiovascular SurLikewise, the prevalence of 1 of the major preoperative
factors was also greater in patients undergoing repair at
age  2.5 months (14% vs 4%, respectively; P<.0001),
largely due to a higher frequency of preoperative mechani-
cal ventilatory support (14% vs 3%; P<.0001). Patients
who underwent CAVSD repair at age  2.5 months had
fewer prior cardiothoracic surgery procedures (7.7% vs
11.1%, respectively; P<.0001).Operative Variables
Median cardiopulmonary bypass time was 126 minutes
(IQR, 98-161). Total crossclamp timewas amedian of 89mi-
nutes (IQR, 68-116). Forty-six patients underwent circula-
tory arrest (median, 21 minutes; IQR, 9.0-30 minutes).
There were no differences in cardiopulmonary bypass time
(mean, 139 59minutes vs 135 56minutes) or crossclamp
time (94  40 minutes vs 96  39 minutes) by age group
(2.5 vs>2.5 months, respectively). Circulatory arrest was
used in 6% of patients aged2.5 months and in 1.4% of pa-
tients aged>2.5 months (P<.001). Avariety of concomitant
procedures were performed at the time of repair of the
CAVSD, including a total of 122 patients (4.6%) who under-
went PAB removal at the time of the CAVSD repair (median
age at CAVSD repair with PAB removal, 8.1 months; IQR,
5.6-13.8 months). Repair of coarctation or other aortic arch
procedure was performed concomitantly with CAVSD repairose with or without Down syndrome
Down syndrome
(n ¼ 1882)
Non-Down syndrome
(n ¼ 517) P value
2 (0.1) 2 (0.4) .1662
74 (3.9) 36 (7.0) .0035
3 (0.2) 1 (0.2) .8667
0 (0) 0 (0) NA
17 (0.9) 12 (2.3) .0090
15 (0.8) 6 (1.2) .4320
78 (4.1) 37 (7.2) .0045
517 (27.5) 150 (29.0) .4881
‘‘Any major preoperative factors.’’
gery c December 2014
TABLE 3. Preoperative factors for the combined overall cohort and for those with age at surgery 2.5 months or>2.5 months
Preoperative factor
Overall
(N ¼ 2399)
Age at surgery
2.5 mo (n ¼ 284)
Age at surgery
>2.5 mo (n ¼ 2115) P value
Mechanical circulatory support* 4 (0.2) 3 (1.1) 1 (0.0) <.0001
Mechanical ventilatory support* 110 (4.6) 39 (13.7) 71 (3.4) <.0001
Renal dysfunction* 4 (0.2) 1 (0.4) 3 (0.1) .4149
Shock—persistent* 0 (0) 0 (0) 0 (0) NA
Seizures 29 (1.2) 2 (0.7) 27 (1.3) .4073
Septicemia 21 (0.9) 2 (0.7) 19 (0.9) .7416
Any major preoperative factors 115 (4.8) 40 (14.1) 75 (3.5) <.0001
Any Society of Thoracic
Surgeons preoperative factors
667 (27.8) 102 (35.9) 565 (26.7) .0012
Values are given as n (%). NA, Not available. *Indicates individual preoperative factors included in ‘‘Any major preoperative factors.’’
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uted among those older or younger than age 2.5 months.
Approximately one-third of patients had concomitant closure
of a patent arterial duct and one-third had closure of an addi-
tional interatrial communication.
In-Hospital Mortality
Overall discharge mortality was 3.0%. Table 4 summa-
rizes associations between discharge mortality and weight
at surgery, age at surgery, and presence or absence of Down
syndrome. Patients at extremes of low weight and age had
worse outcomes. Discharge mortality was higher among
those without Down syndrome than among those with
Down syndrome (4.4% vs 2.6%, respectively; P ¼ .03).
For the 122 patients who underwent PAB removal at the
time of CAVSD repair, discharge mortality was 4.1% (5
deaths).
Postoperative Complications and Length of Stay
Of the entire cohort, 50% of patients experienced 1
complications as coded in STS-CHSD (exclusive ofTABLE 4. Distributions of outcomes by patient factors
Frequency,
n (%)
In-hospital
mortality (%)
Postoperative lengt
stay (median, IQR
Weight at surgery
<3.5 kg 151 (6.3) 15.2 14 (8-32)
3.5 kg 2247 (93.7) 2.2 8 (5-14)
P value — <.0001 <.0001
Age at surgery
2.5 mo 284 (11.8) 9.5 12 (8-25)
>2.5 mo 2115 (88.2) 2.1 7 (5-13)
P value — <.0001 <.0001
Down syndrome
No 517 (21.6) 4.4 8 (5-16)
Yes 1882 (78.4) 2.6 8 (6-14)
P value — .03 .34
Overall 2399 (100) 3.0 8 (5-14)
IQR, Interquartile range. *Major complications include renal failure requiring dialysis, neu
manent pacemaker, postoperative mechanical circulatory support, phrenic nerve injury, an
The Journal of Thoracic and Carintraoperative death and sternum left open), and 9.8% of pa-
tients experienced1 of the 6 major complications included
in the STS Congenital Heart Surgery Morbidity Score.14
Table 4 summarizes the frequency of occurrence of 1 ma-
jor complications and of reoperations with cardiopulmonary
bypass after repair of CAVSD and during the same hospital
admission across patient groups stratified by weight at sur-
gery, age at surgery, and presence or absence of Down syn-
drome. Weight<3.5 kg and age  2.5 months were both
associated with higher rates of discharge mortality, longer
PLOS, and higher frequency of occurrence of major compli-
cations. Patients with Down syndrome had lower rates of
major complications than those without Down syndrome.
PLOS was similar for both groups. Frequency of reopera-
tions with cardiopulmonary bypass during the same admis-
sion was unrelated to weight at surgery, but was higher in
the younger age group (2.5 months) and among those
without Down syndrome. Although 12.1% of the entire
cohort was reported to require temporary pacing for
arrhythmia, only 2.7% underwent permanent pacemaker
implantation either concomitantly or subsequent to repairh of
)
Complications (%, with 1 or
more major complications*)
Reoperations with
cardiopulmonary bypass
before discharge (%)
16.6 4.0
9.4 3.0
<.01 .49
13.4 7.0
9.4 2.5
.03 <.0001
15.1 5.4
8.4 2.4
<.0001 <.001
9.8 3.0
rologic deficit persisting at discharge, atrioventricular block/arrhythmia requiring per-
d unplanned reoperations.
diovascular Surgery c Volume 148, Number 6 2529
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with heart block requiring a permanent pacer relative to the
presence of Down syndrome or the age at operation. Reop-
eration for postoperative bleeding occurred in 1.3% of
cases. Approximately 3% of patients underwent an addi-
tional subsequent procedure requiring cardiopulmonary
bypass during the same admission, whereas 8% had a proce-
dure not requiring cardiopulmonary bypass.
Comments
We report early outcomes of CAVSD repair across a large
multicenter cohort, providing a contemporary snapshot of
practices at centers in North America and shedding light
on associations of outcomes with such factors as extremes
of low weight and age and Down syndrome. Overall in-
hospital mortality of 3% is consistent with rates reported
recently from individual centers and from a PHN multi-
center study that included data from 7 institutions.7,9
Given the prevalence of Down syndrome among patients
with CAVSD, an understanding of associations between this
genetic syndrome and outcomes is important. Evans and
colleagues15 recently reported an analysis of administrative
data (Kids’ Inpatient Database) that evaluated the associa-
tion between Down syndrome and in-hospital death among
children undergoing surgery for congenital heart disease.
These investigators found that children with Down syn-
drome who underwent repair of congenital heart disease
were more likely to survive to discharge than children
without Down syndrome. Although their cohort was large,
and they analyzed outcomes across the strata of procedural
risk defined by Risk Adjustment for Congenital Heart Sur-
gery classification levels, they did not evaluate specific
diagnostic or procedural groups and offered no data or infer-
ences related to repair of CAVSD. Our study does provide
this additional specific information.
To varying degrees, management of infants with CAVSD
and Down syndrome has, in the past, been influenced by
many assumptions concerning pulmonary function, airway
and vascular reactivity, and predisposition to various mor-
bidities. Our data clearly attest to lower overall hospital
mortality, fewer major complications, and fewer reopera-
tions with bypass before discharge among Down syndrome
patients. In addition, their PLOS is not different from that of
patients without Down syndrome. An often described
observation is that patients with CAVSD and Down syn-
drome have less variability in the morphology of the com-
mon atrioventricular valve than do patients without Down
syndrome. If so, this may have a favorable influence on
the physiologic results after repair. If this is true in our
STS-CHSD cohort could not be evaluated, because perti-
nent details concerning morphology are not captured in
the database.
Whereas the age at which infants generally undergo
CAVSD repair has declined significantly during the past2530 The Journal of Thoracic and Cardiovascular Surfew decades, ideal timing of repair is still debated.6,8-11
One of the important goals of early repair is to prevent
the development of irreversible pulmonary vascular
disease, which can be found as early as age 6 months.16
Additional benefits of early repair include decreasing the
risk of developing degenerative changes, including thick-
ening of the common atrioventricular valve and decreasing
the risk of prolonged failure to thrive.17,18 However, in very
young infants, fragility of the common atrioventricular
valve tissue may increase the technical challenge. Most
published reports favor early repair and define early repair
as younger than age 6 months.6-8,10 There is a paucity of
literature analyzing the risks and benefits of repair at a
very young age such as 1 to 3 months.
In our study, 11.8% of patients (n¼ 284) underwent sur-
gery at age  2.5 months. These patients had worse out-
comes with higher rates of discharge mortality, longer
PLOS, and higher frequency of occurrence of 1 major
complications. In addition, frequency of reoperations
with cardiopulmonary bypass was higher in this younger
cohort. These data add to the findings of a smaller PHN
study in which Atz and colleagues9 noted that repair at
age  2.5 months was associated with longer hospital
stay, longer intensive care unit stay, longer ventilator
use, and greater complication rates. They also noted a
trend toward greater mortality by age 6 months and greater
need for reoperation within the first 6 months. Given the
small size of their cohort, the number of in-hospital deaths
was too small to empower a statistically meaningful
analysis.
Several reports have explored associations between age
at surgery, weight at surgery, and outcomes. Weight and
age are closely related, but not necessarily as consistently
or predictably in patients with CAVSD as in infants without
congenital heart disease. Congestive heart failure and pul-
monary artery hypertension are associated with feeding dif-
ficulties, abnormal energy expenditure, and failure to thrive.
Waiting for weight gain can be a risky and unpredictable
strategy. Prifti and colleagues19 explored associations be-
tween weight and postoperative outcomes of CAVSD repair
and noted that weight<5 kg at the time of repair (median
age, 4.3 months) was associated with a high rate of late re-
operation for left atrioventricular valve regurgitation. In
contrast, Suzuki and colleagues5 reported a higher inci-
dence of preoperative left atrioventricular valve regurgita-
tion in infants who underwent repair at age<3 months,
but no difference in postoperative residual regurgitation or
reoperation for left atrioventricular valve dysfunction.
Similarly, Reddy and colleagues20 reported on a series of
72 infants with repair at median age of 3.9 months
(40%< 3 months) and concluded that age at repair does
not influence outcome or valve function. With the exception
of the study by Atz and colleagues,9 the above-mentioned
reports all describe single institution experiences that reflectgery c December 2014
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management.C
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DLimitations
This descriptive analysis is based on a very large multi-
institutional cohort and provides important information
about current patterns of practice as well as benchmark
data concerning early outcomes. The study results must,
however, be interpreted with caution. The preoperative
data fields in the STS-CHSD at the time of the study lacked
sufficient granularity to support development of multivari-
able risk models that might guide surgical decision mak-
ing. At the time of our study the database did not gather
information regarding specific morphologic and physio-
logic details and procedural variables related to CAVSD
repair that may be related to timing of surgery and to out-
comes. Specifically, before 2014, database fields did not
include degree of preoperative atrioventricular valve
regurgitation, morphology of common atrioventricular
valve (eg, single left-sided papillary muscle, deficient
mural leaflet, or double orifice), ventricular imbalance,
and other patient-specific factors that may be related to
the risk of poor outcomes, such as degree of atrioventric-
ular valve regurgitation. For a multivariable risk factor
analysis to be informative, it would be necessary to include
such variables. Based only on the data currently available
in the STS Database, it is not possible to ascertain if some
individual patients had surgery very early in infancy or at
very low weight because of unfavorable morphology, an
extreme degree of physiologic compromise, or other rea-
sons. Additional fields that relate specifically to repair of
CAVSD have recently been added to the STS-CHSD.
These pertain to degree of preoperative atrioventricular
valve regurgitation; malalignment or unbalance of the
defect and the common atrioventricular valve; and other
surgically relevant morphologic details such as single
papillary muscle, deficient posterior mural leaflet, and
double orifice left atrioventricular valve.CONCLUSIONS
In a large contemporary multicenter cohort, most patients
with CAVSD underwent operation early during the first year
of life. Mortality and major complication rates are lower for
patients with Down syndrome than for those without.
Although overall mortality is generally low for the entire
cohort of patients undergoing repair of CAVSD, patients
at extremes of low weight and age have worse outcomes.
Incorporation into the STS-CHSD in 2014 of a complementThe Journal of Thoracic and Carof fields pertaining specifically to repair of CAVSD may
facilitate risk stratification of these challenging patients.
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